featured
Managing Metastatic Breast Cancer: An Interview With Lee Schwartzberg, Reshma Mahtani, and Lillie Shockney—Part 4
- PracticeUpdate Editorial Team
Interview with
Interview with
Interview with
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Managing Metastatic Breast Cancer: An Interview With Lee Schwartzberg, Reshma Mahtani, and Lillie Shockney—Part 1
- Managing Metastatic Breast Cancer: An Interview With Lee Schwartzberg, Reshma Mahtani, and Lillie Shockney—Part 2
- Managing Metastatic Breast Cancer: An Interview With Lee Schwartzberg, Reshma Mahtani, and Lillie Shockney—Part 3
- Managing Metastatic Breast Cancer: An Interview With Lee Schwartzberg, Reshma Mahtani, and Lillie Shockney—Part 5
-
Mehta RS, Barlow WE, Albain KS, et al: A phase III randomized trial of anastrozole versus anastrozole and fulvestrant as first-line therapy for postmenopausal women with metastatic breast cancer: SWOG S0226. Paper presented at: 2011 San Antonio Breast Cancer Symposium; December 6-11, 2011; San Antonio, TX. Abstract S1-1.
- Rugo HS, Seneviratne L, Beck JT, et al. Prevention of everolimus/exemestane (EVE/EXE) stomatitis in postmenopausal (PM) women with hormone receptor-positive (HR+) metastatic breast cancer (MBC) using a dexamethasone-based mouthwash (MW): Results of the SWISH trial. Paper presented at: 2016 Annual Meeting of the American Society of Clinical Oncology; June 3-7, 2016; Chicago, IL. Abstract 525.
Disclosure statements are available on the authors' profiles: